User name
Password

Don't have a user name yet?
Register here.

Help

Lek announces more focus on innovative drugs

Ljubljana, 5 February - Addressing the press on Wednesday amid continuing speculation about the plans of Novartis, representatives of the Swiss multinational's Slovenian subsidiary Lek said Novartis would continue a reform in Slovenia that included the transformation of production locations and more focus on innovative drugs along with generics.

Ljubljana
Pharma company Lek.
Photo: Bor Slana/STA

The rest of this news item is available to subscribers.
The news item consists of 1.662 characters (without spaces) or 315 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

gz/ep
© STA, 2020